These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31293053)

  • 41. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
    Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
    Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefits of the 8th American Joint Committee on Cancer System for Hepatocellular Carcinoma Staging.
    Satala CB; Jung I; Kobori L; Kovacs Z; Fodor D; Szodorai R; Gurzu S
    J Gastrointest Cancer; 2021 Mar; 52(1):243-248. PubMed ID: 32173767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
    Abdel-Rahman O
    PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revisiting the AJCC staging system of adrenocortical carcinoma.
    Abdel-Rahman O
    J Endocrinol Invest; 2022 Jan; 45(1):89-94. PubMed ID: 34170487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Staging soft tissue sarcoma of the head and neck: Evaluation of the AJCC 8th edition revised T classifications.
    Cates JMM
    Head Neck; 2019 Jul; 41(7):2359-2366. PubMed ID: 30779403
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modified staging classification of gallbladder carcinoma on the basis of the 8
    Wang J; Bo X; Shi X; Suo T; Xin Y; Nan L; Wang C; Ni X; Liu H; Pan H; Shen S; Li M; Lu P; Zhang D; Wang Z; Wang Y; Liu H
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):527-533. PubMed ID: 31630931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The predictive value of the prognostic staging system in the 8th edition of the American Joint Committee on Cancer for triple-negative breast cancer: a SEER population-based analysis.
    Liu YY; Yu TJ; Liu GY
    Future Oncol; 2019 Feb; 15(4):391-400. PubMed ID: 30620221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploration of the Exact Prognostic Significance of Lymphatic Metastasis in Jejunoileal Neuroendocrine Tumors.
    Chen L; Song Y; Zhang Y; Chen M; Chen J
    Ann Surg Oncol; 2018 Jul; 25(7):2067-2074. PubMed ID: 29748891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.
    He X; Wu W; Lin Z; Ding Y; Si J; Sun LM
    Gastric Cancer; 2018 May; 21(3):391-400. PubMed ID: 29052053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Performance Analysis of the American Joint Committee on Cancer 8th Edition Staging System for Retroperitoneal Sarcoma and Development of a New Staging Algorithm for Sarcoma-Specific Survival.
    Cates JMM
    Ann Surg Oncol; 2017 Dec; 24(13):3880-3887. PubMed ID: 29058143
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
    Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
    Ellison TA; Wolfgang CL; Shi C; Cameron JL; Murakami P; Mun LJ; Singhi AD; Cornish TC; Olino K; Meriden Z; Choti M; Diaz LA; Pawlik TM; Schulick RD; Hruban RH; Edil BH
    Ann Surg; 2014 Feb; 259(2):204-12. PubMed ID: 23673766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Staging System for Neuroendocrine Tumors of the Lung Needs to Incorporate Histologic Grade.
    Jackson AS; Rosenthal A; Cattoni M; Bograd AJ; Farivar AS; Aye RW; Vallières E; Louie BE
    Ann Thorac Surg; 2020 Apr; 109(4):1009-1018. PubMed ID: 31706866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers].
    Zhang Y; Peng X; Jin K; Wang W; Feng X; Zeng Y; Chen M; Yu X; Chen Y; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1235-1240. PubMed ID: 27928792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
    Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK
    J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The latest exploration of staging and prognostic classification for pancreatic neuroendocrine tumors: a large population-based study.
    Gao S; Pu N; Liu L; Li C; Xu X; Wang X; Lou W
    J Cancer; 2018; 9(9):1698-1706. PubMed ID: 29760809
    [No Abstract]   [Full Text] [Related]  

  • 60. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
    Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
    J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.